The identification of Lynch syndrome in British Columbia

Canadian Journal of Gastroenterology

Volumn 23, Issue 11, 2009, Pages 761-767

  Cremin, Carol M ^a   Armstrong, Linlea ^b   Gill, Sharlene ^a   Huntsman, David ^c   Bajdik, Chris ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Colon cancer; Genetic testing; Hereditary; HNPCC; Lynch syndrome

Indexed keywords

B RAF KINASE; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL PROTOCOL; COLORECTAL CANCER; FAMILIAL CANCER; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PEDIGREE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 73349091799     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/620518     Document Type: Article

References (30)

1. Jass JR. Hereditary non-polyposis colorectal cancer: The rise and fall of a confusing term. World J Gastroenterol 2006;12:4943-50.
2. Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency; familial colorectal cancer type X. JAMA 2005;293:1979-85.
3. Aaltonen L, Peltomaki P, Mecklin J, et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994;54:1645-8.
4. Lynch H, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999;36:801-18.
5. Vasen H, Watson P, Mecklin JP, Lynch H. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC/Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroeonterology 1999;116:1453-6.
6. Jarvninen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829-34.
7. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368:258-61.
8. Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its assocaition with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
9. Miyaki M, Konishi M, Tanaka K, et al. Germline mutation of MSH6 as cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997;17:271-2.
10. Akiyama Y, Sato H, Yamada T, et al. Germline mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 1997;57:3920-3.
11. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
12. Peltomaki P. Lynch syndrome genes. Fam Cancer 2005;4:227-32.
13. Vasen, HF, Mecklin JP, Khan PM, et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
14. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-8.
15. Jasperson K, Lowstuter K, Weitzel J. Assessing the predictive accuracy of hMLH1 and hMSH2 mutation probability models. J Gen Counsel 2006;15:339-47.
16. Hendriks YM, de Jong AE, Hans Morreau, et al. Diagnostic approach and management of Lynch syndrome (Hereditary nonpolyposis colorectal carcinoma): A guide for clinicians. CA Cancer J Clin 2006;56:213-25.
17. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition; development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
18. Lindor N, Rabe K, Petersen G, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency. JAMA 2005;293:1979-85.
19. Loughrey MB, Waring PM, Tan A. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary nonpolyposis colorectal cancer. Fam Cancer 2007;6:301-10.
20. Molsein G, Tester DJ, Lindor NM, et al. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet 1996;5:1245-52.
21. Kievit W, de Bruin JH, Adang EM, et al. Current clinical selection strategies for identification of hereditary nonpolyposis colorectal cancer families are inadequate: A meta-analysis. Clin Genet 2004;65:308-16.
22. Syngal S, Fox EA, Eng C, et al. Sensitivity and specificity of clinical criteria for hereditary nonpolyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 2000;37:641-9.
23. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients. Nat Med 1996;2:169-74.
24. Winjen J, Khan PM, Vasen H, et al. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair gene mutations. Am J Hum Genet 1997;61:329-35.
25. Wagner A, Barrows A, Wijnen JT, et al. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: High mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 2003;72:1088-100.
26. Black D, Soslow RA, Levine DA, et al. Clinicopathologic significance of defective DNA mistmatch repair in endometrial carcinoma. J Clin Oncol 2006;24:1745-53.
27. Lu K, Schorge O, Rodabaugh K, et al. Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer. J Clin Oncol 2007;25:5158-64.
28. Chen S, Wang W, Lee S, et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 2006;296:1479-87.
29. Myriad Genetics: Mutation prevalence tables for HNPCC genes, November 2007. «http://www.myriadtests.com/provider/ mutprevhnpcc.htm» (Version current at November 10, 2008).
30. Bajdik CD, Sung S, Spinelli JJ, et al. Predicting the performance of a genetic testing service for cancer susceptibility. Genet Test 2007;11:381-6.